Neuried, Germany

Ingo Klagge

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 5.7

ph-index = 1

Forward Citations = 9(Granted Patents)


Location History:

  • Neuried, DE (2012 - 2015)
  • Planegg, DE (2016)

Company Filing History:


Years Active: 2012-2016

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Ingo Klagge: Innovator in Therapeutic Antibodies

Introduction

Ingo Klagge is a notable inventor based in Neuried, Germany. He has made significant contributions to the field of therapeutic antibodies, holding a total of 5 patents. His work focuses on innovative solutions for treating various autoimmune and inflammatory disorders.

Latest Patents

Klagge's latest patents include groundbreaking research on compositions and methods of use for therapeutic low density lipoprotein-related protein 6 (LRP6) multivalent antibodies. This patent relates to antibodies targeting LRP and the compositions and methods of use thereof. Another significant patent involves anti-IL12Rβ1 antibodies and their application in treating autoimmune and inflammatory disorders. This invention specifically addresses antibodies that bind to IL12Rβ1, which is crucial for inhibiting IL12/IL18 induced IFNγ production in blood cells. The methods and compositions derived from this research aim to treat conditions such as rheumatoid arthritis, psoriasis, and inflammatory bowel diseases.

Career Highlights

Ingo Klagge is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on developing innovative therapeutic solutions that address critical health challenges.

Collaborations

Klagge has collaborated with esteemed colleagues such as Stefan Hartle and Christoph Heusser. These partnerships have further enhanced his research and development efforts in the field of therapeutic antibodies.

Conclusion

Ingo Klagge's contributions to the field of therapeutic antibodies are noteworthy, with a focus on innovative treatments for autoimmune and inflammatory disorders. His patents reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…